Matches in SemOpenAlex for { <https://semopenalex.org/work/W1556650974> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W1556650974 endingPage "261" @default.
- W1556650974 startingPage "256" @default.
- W1556650974 abstract "Objectives Renal function may progressively decline in patients with Fabry disease. This study assessed pharmacokinetics, safety, and tolerability of a single oral dose of migalastat HCl 150 mg in subjects with normal or mildly, moderately, or severely impaired renal function. Methods Volunteers were enrolled into two cohorts stratified for renal function calculated using the Cockcroft–Gault equation for creatinine clearance. Pharmacokinetic parameters determined were: area under the concentration–time curve (AUC) from time zero to the last measurable concentration postdose (AUC0–t) and extrapolated to infinity (AUC0–∞), maximum observed concentration (Cmax), time to Cmax (tmax), concentration at 48 hours postdose (C48h), terminal elimination half-life (t1/2), oral clearance (CL/F), and apparent terminal elimination rate constant (λz) (ClinicalTrials.gov registration: NCT01730469). Results Thirty-two subjects enrolled and completed the study (Cohort 1: n = 24; Cohort 2: n = 8). Migalastat clearance decreased with increasing renal impairment, resulting in increases in migalastat HCl plasma t1/2, AUC0–∞, and C48h compared with subjects with normal renal function. Incidence of adverse events was comparable across all renal function groups. Conclusions Plasma migalastat clearance decreased as degree of renal impairment increased. Data from the migalastat HCl clinical program will guide dosing and intervals for patients with Fabry disease with renal impairment." @default.
- W1556650974 created "2016-06-24" @default.
- W1556650974 creator A5011232768 @default.
- W1556650974 creator A5025279301 @default.
- W1556650974 creator A5033423082 @default.
- W1556650974 creator A5038788610 @default.
- W1556650974 creator A5051476563 @default.
- W1556650974 creator A5057063044 @default.
- W1556650974 creator A5078893992 @default.
- W1556650974 date "2014-12-22" @default.
- W1556650974 modified "2023-09-30" @default.
- W1556650974 title "An open-label study to determine the pharmacokinetics and safety of migalastat HCl in subjects with impaired renal function and healthy subjects with normal renal function" @default.
- W1556650974 cites W1602695946 @default.
- W1556650974 cites W1985634863 @default.
- W1556650974 cites W2001951305 @default.
- W1556650974 cites W2026893678 @default.
- W1556650974 cites W2037698344 @default.
- W1556650974 cites W2089151273 @default.
- W1556650974 cites W2140375980 @default.
- W1556650974 cites W87011223 @default.
- W1556650974 doi "https://doi.org/10.1002/cpdd.149" @default.
- W1556650974 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27136905" @default.
- W1556650974 hasPublicationYear "2014" @default.
- W1556650974 type Work @default.
- W1556650974 sameAs 1556650974 @default.
- W1556650974 citedByCount "12" @default.
- W1556650974 countsByYear W15566509742018 @default.
- W1556650974 countsByYear W15566509742019 @default.
- W1556650974 countsByYear W15566509742021 @default.
- W1556650974 countsByYear W15566509742022 @default.
- W1556650974 countsByYear W15566509742023 @default.
- W1556650974 crossrefType "journal-article" @default.
- W1556650974 hasAuthorship W1556650974A5011232768 @default.
- W1556650974 hasAuthorship W1556650974A5025279301 @default.
- W1556650974 hasAuthorship W1556650974A5033423082 @default.
- W1556650974 hasAuthorship W1556650974A5038788610 @default.
- W1556650974 hasAuthorship W1556650974A5051476563 @default.
- W1556650974 hasAuthorship W1556650974A5057063044 @default.
- W1556650974 hasAuthorship W1556650974A5078893992 @default.
- W1556650974 hasConcept C112705442 @default.
- W1556650974 hasConcept C126322002 @default.
- W1556650974 hasConcept C126894567 @default.
- W1556650974 hasConcept C159641895 @default.
- W1556650974 hasConcept C22979827 @default.
- W1556650974 hasConcept C2777288759 @default.
- W1556650974 hasConcept C2908822073 @default.
- W1556650974 hasConcept C71924100 @default.
- W1556650974 hasConcept C72563966 @default.
- W1556650974 hasConcept C98274493 @default.
- W1556650974 hasConceptScore W1556650974C112705442 @default.
- W1556650974 hasConceptScore W1556650974C126322002 @default.
- W1556650974 hasConceptScore W1556650974C126894567 @default.
- W1556650974 hasConceptScore W1556650974C159641895 @default.
- W1556650974 hasConceptScore W1556650974C22979827 @default.
- W1556650974 hasConceptScore W1556650974C2777288759 @default.
- W1556650974 hasConceptScore W1556650974C2908822073 @default.
- W1556650974 hasConceptScore W1556650974C71924100 @default.
- W1556650974 hasConceptScore W1556650974C72563966 @default.
- W1556650974 hasConceptScore W1556650974C98274493 @default.
- W1556650974 hasIssue "4" @default.
- W1556650974 hasLocation W15566509741 @default.
- W1556650974 hasLocation W15566509742 @default.
- W1556650974 hasOpenAccess W1556650974 @default.
- W1556650974 hasPrimaryLocation W15566509741 @default.
- W1556650974 hasRelatedWork W2064759457 @default.
- W1556650974 hasRelatedWork W2370929226 @default.
- W1556650974 hasRelatedWork W2379280247 @default.
- W1556650974 hasRelatedWork W2766550598 @default.
- W1556650974 hasRelatedWork W2942467058 @default.
- W1556650974 hasRelatedWork W2945264506 @default.
- W1556650974 hasRelatedWork W3018168093 @default.
- W1556650974 hasRelatedWork W3080423469 @default.
- W1556650974 hasRelatedWork W3122926187 @default.
- W1556650974 hasRelatedWork W3151787567 @default.
- W1556650974 hasVolume "4" @default.
- W1556650974 isParatext "false" @default.
- W1556650974 isRetracted "false" @default.
- W1556650974 magId "1556650974" @default.
- W1556650974 workType "article" @default.